News

We’re proud to have supported the Cancer Revolution: Science, Innovation and Hope exhibition. 

We marched to Number 10 Downing Street to amplify the voices of 20,000 people who have signed our open letter demanding that the government take urgent action to save lives. 

In February we, as part of One Cancer Voice, set out 10 tests that the new 10-year Cancer Plan must meet to be successful in delivering world-leading and transformative change for cancer patients.

A reminder why we fight: latest ovarian cancer data from NHS Digital reveals injustices that disproportionately affect those who die from ovarian cancer.

Announcement that niraparib from second line of treatment for recurrent ovarian cancer will be available long term on the NHS in England and Wales.

New data reveals how aware the UK is of ovarian cancer and its symptoms.

Our new report confirms ovarian cancer has the second longest treatment wait times of all cancers.

Annwen Jones OBE, Chief Executive of Target Ovarian Cancer, becomes Chair of the World Ovarian Cancer Coalition.

Our first ever digital conference Moving Forwards Together was just the beginning...

New combination of olaparib and bevacizumab means a leap forward in personalised treatments.

Initial decision announced to make niraparib available from second line of treatment only to people with a BRCA1 or BRCA2 mutation.

Your donations will be matched pound for pound, up to £30,000!